Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation: Models in Discovery and Translation
Editat de Gerard Socie, Robert Zeiser, Bruce R. Blazaren Limba Engleză Hardback – 6 dec 2018
- Brings together perspectives from leading laboratories and clinical research groups to highlight advances from bench to the bedside
- Guides readers through the caveats that must be considered when drawing conclusions from studies with animal models before correlating to clinical allogeneic hematopoietic stem cell transplantation (HSCT) scenarios
- Categorizes the published advances in various aspects of immune biology of allogeneic HSCT to illustrate opportunities for clinical applications
Preț: 927.82 lei
Preț vechi: 1273.68 lei
-27% Nou
Puncte Express: 1392
Preț estimativ în valută:
177.53€ • 185.36$ • 146.94£
177.53€ • 185.36$ • 146.94£
Carte tipărită la comandă
Livrare economică 29 martie-12 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128126301
ISBN-10: 0128126302
Pagini: 430
Dimensiuni: 216 x 276 x 32 mm
Ediția:2
Editura: ELSEVIER SCIENCE
ISBN-10: 0128126302
Pagini: 430
Dimensiuni: 216 x 276 x 32 mm
Ediția:2
Editura: ELSEVIER SCIENCE
Public țintă
Stem cell biologists, immunologists, hematologists, cancer biologists and oncologists.Cuprins
1. Overview
2. HLA system
3. Minor Ag
4. In vivo imaging
5. Engraftment, graft rejection and graft failure
6. Immune regeneration or immune recovery
7. Tumor associated antigens
8. Genetically engineered T cell therapies and immune system engagers for GVHD and GvL
9. Microbiome
10. micro-RNA and kinase regulatory mechanisms and pathways in GVHD
11. Costimulation vs. Inhibition
12. Th1/2 and TC1/2
13. Treg
14. Th17
15. B and T cells in chronic GVHD
16. NK
17. Cytokines
18. Chemokines
19. Metabolism and intracellular sensor
20. Omics
21. Endothelium and stroma
22. Future
2. HLA system
3. Minor Ag
4. In vivo imaging
5. Engraftment, graft rejection and graft failure
6. Immune regeneration or immune recovery
7. Tumor associated antigens
8. Genetically engineered T cell therapies and immune system engagers for GVHD and GvL
9. Microbiome
10. micro-RNA and kinase regulatory mechanisms and pathways in GVHD
11. Costimulation vs. Inhibition
12. Th1/2 and TC1/2
13. Treg
14. Th17
15. B and T cells in chronic GVHD
16. NK
17. Cytokines
18. Chemokines
19. Metabolism and intracellular sensor
20. Omics
21. Endothelium and stroma
22. Future